Literature DB >> 14454739

The metabolism of gluethimide (Doriden).

H KEBERLE, K HOFFMANN, K BERNHARD.   

Abstract

Entities:  

Keywords:  HYPNOTICS AND SEDATIVES/metabolism

Mesh:

Substances:

Year:  1962        PMID: 14454739     DOI: 10.1007/bf02153841

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  6 in total

1.  [Pharmacological characteristics of the soporific doriden].

Authors:  F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1955-03-26

2.  [Determination of the duration of detoxications in the liver by bile analysis].

Authors:  K BERNHARD; M JUST; J P VUILLEUMIER
Journal:  Helv Physiol Pharmacol Acta       Date:  1957

3.  The metabolism of barbiturates.

Authors:  E W MAYNERT; H B VAN DYKE
Journal:  Pharmacol Rev       Date:  1949       Impact factor: 25.468

4.  The role of body fat in limiting the duration of action of thiopental.

Authors:  B B BRODIE; E BERNSTEIN; L C MARK
Journal:  J Pharmacol Exp Ther       Date:  1952-08       Impact factor: 4.030

5.  The absence of localization of barbital in divisions of the central nervous system.

Authors:  E W MAYNERT; H B VAN DYKE
Journal:  J Pharmacol Exp Ther       Date:  1950-02       Impact factor: 4.030

6.  [The elimination rate of glutethimide (Doriden) in man].

Authors:  H REMMER; G NEUHAUS; K IBE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1961
  6 in total
  6 in total

1.  [THE ELIMINATION OF GLUTETHIMIDE AND OF LONG-ACTING BARBITURATES AFTER TOXICALLY AND THERAPEUTICALLY EFFECTIVE DOSES].

Authors:  H REMMER; M SIEGERT; G NEUHAUS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963-09-02

Review 2.  Aminoglutethimide: a "side-effect" turned to therapeutic advantage.

Authors:  S W Hughss; D M Burley
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

3.  Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

Authors:  C F George; T Fenyvesi; M E Conolly; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

4.  Inhibition of glutethimide absorption.

Authors:  Y Kamisaka; D W Griffiths; L Leduc; M Lipsky; H Martin; W R Thayer
Journal:  Arch Toxikol       Date:  1971

5.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

6.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.